Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future

References

• FIND. COVID-19 pipeline; 2021 [cited 2021 Nov 30]. Available from: https://www.finddx.org/covid-19/pipeline/
   Google Scholar
• European Centre for Disease Prevention and Control. Testing strategies for SARS-CoV-2; 2021 [cited 2021 Nov 30]. Available from: https://www.ecdc.europa.eu/en/covid-19/surveillance/testing-strategies
   Google Scholar
• WHO. Diagnostic testing for SARS-CoV-2; 2020 [cited 2021 Nov 30]. Available from: https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2
   Google Scholar
• Arevalo-Rodriguez I, Seron P, Buitrago-Garcia D, et al. Recommendations for SARS-CoV-2/COVID-19 testing: a scoping review of current guidance. BMJ Open. 2021;11(1):e043004.
   PubMed Web of Science ®Google Scholar
• Faust L, Zimmer AJ, Kohli M, et al. SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector. Microbes Infect. 2020;22(10):511–514.
   PubMed Web of Science ®Google Scholar
• Mostafa HH, Hardick J, Morehead E, et al. Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays. J Clin Virol. 2020;130:104578.
   PubMed Web of Science ®Google Scholar
• Yu CY, Chan KG, Yean CY, et al. Nucleic acid-based diagnostic tests for the detection SARS-CoV-2: an update. Diagnostics. 2021;11(1):53.
   Web of Science ®Google Scholar
• FDA. SARS-CoV-2 reference panel comparative data; 2020 [cited 2021 Nov 30]. Available from: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-reference-panel-comparative-data
   Google Scholar
• Hologic. Hologic SARS-CoV-2 assays; 2021 [cited 2021 Mar]. Available from: https://www.hologic.com/hologic-products/diagnostic-solutions/hologic-sars-cov-2-assays
   Google Scholar
• Rodel J, Egerer R, Suleyman A, et al. Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis. J Clin Virol. 2020;132:104616.
   PubMed Web of Science ®Google Scholar
• Roche Diagnostics. Elecsys SARS-CoV-2 antigen; 2021 [cited 2021 Mar]. Available from: https://diagnostics.roche.com/global/en/products/params/elecsys-sars-cov-2-antigen-test.html
   Google Scholar
• Hayer J, Kasapic D, Zemmrich C. Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: a systematic meta-analysis of available data as of November 20, 2020. Int J Infect Dis. 2021;108:592–602.
   PubMed Web of Science ®Google Scholar
• FDA. EUA authorized serology test performance; 2021 [cited 2021 Mar]. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/eua-authorized-serology-test-performance
   Google Scholar
• WHO. COVID-19 target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0; 2020 [cited 2021 Nov 30]. Available from: https://www.who.int/publications/m/item/covid-19-target-product-profiles-for-priority-diagnostics-to-support-response-to-the-covid-19-pandemic-v.0.1
   Google Scholar
• Wirden M, Feghoul L, Bertine M, et al. Multicenter comparison of the cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2. J Clin Virol. 2020;130:104573.
   PubMed Web of Science ®Google Scholar
• Gorzalski AJ, Tian H, Laverdure C, et al. High-throughput transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2. J Clin Virol. 2020;129:104501.
   PubMed Web of Science ®Google Scholar
• Fowler VL, Armson B, Gonzales JL, et al. A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection. J Infect. 2021;82(1):117–125.
   PubMed Web of Science ®Google Scholar
• Mautner L, Baillie CK, Herold HM, et al. Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J. 2020;17(1):160.
   PubMed Web of Science ®Google Scholar
• Osterdahl MF, Lee KA, Lochlainn MN, et al. Detecting SARS-CoV-2 at point of care: preliminary data comparing loop-mediated isothermal amplification (LAMP) to polymerase chain reaction (PCR). BMC Infect Dis. 2020;20(1):783.
   PubMed Web of Science ®Google Scholar
• Freire-Paspuel B, Garcia-Bereguiain MA. Low clinical performance of Isopollo COVID-19 detection kit (M Monitor, South Korea) for RT-LAMP SARS-CoV-2 diagnosis: a call for action against low quality products for developing countries. Int J Infect Dis. 2021;104:303–305.
   PubMed Web of Science ®Google Scholar
• Iacobucci G. Covid-19: mass population testing is rolled out in Liverpool. BMJ. 2020;371:m4268.
   PubMedGoogle Scholar
• Iacobucci G. Covid-19: rapid test missed over 50% of positive cases in Manchester pilot. BMJ. 2020;371:m4323.
   PubMedGoogle Scholar
• UK Department of Health and Social Care. Clinical evaluation confirms accuracy of LAMP test: Gov.uk; 2020 [cited 2021 Nov 30]. Available from: https://www.gov.uk/government/news/clinical-evaluation-confirms-accuracy-of-lamp-test
   Google Scholar
• Lanser L, Bellmann-Weiler R, Ottl KW, et al. Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values. Infection. 2021;49(3):555–557.
   PubMed Web of Science ®Google Scholar
• Mattiuzzi C, Henry BM, Lippi G. Making sense of rapid antigen testing in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnostics. Diagnosis. 2021;8(1):27–31.
   Web of Science ®Google Scholar
• Dinnes J, Deeks JJ, Adriano A, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;(8):CD013705.
   PubMedGoogle Scholar
• Lindner AK, Nikolai O, Kausch F, et al. Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab. Eur Respir J. 2021;57(4):2003961.
   PubMed Web of Science ®Google Scholar
• Houston H, Gupta-Wright A, Toke-Bjolgerud E, et al. Diagnostic accuracy and utility of SARS-CoV-2 antigen lateral flow assays in medical admissions with possible COVID-19. J Hosp Infect. 2021;110:203–205.
   PubMed Web of Science ®Google Scholar
• Guglielmi G. Fast coronavirus tests: what they can and can't do. Nature. 2020;585:496–498.
   PubMed Web of Science ®Google Scholar
• Chen M, Qin R, Jiang M, et al. Clinical applications of detecting IgG, IgM or IgA antibody for the diagnosis of COVID-19: a meta-analysis and systematic review. Int J Infect Dis. 2021;104:415–422.
   PubMed Web of Science ®Google Scholar
• Pisanic N, Randad PR, Kruczynski K, et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. J Clin Microbiol. 2020;59(1):e02204-20.
   PubMed Web of Science ®Google Scholar
• Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845–848.
   PubMed Web of Science ®Google Scholar
• Röltgen K, Powell AE, Wirz OF, et al. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Sci Immunol. 2020;5(54):eabe0240.
   PubMed Web of Science ®Google Scholar
• Schaffner A, Risch L, Weber M, et al. Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study. Clin Chem Lab Med. 2020;59(2):e49–e51.
   PubMed Web of Science ®Google Scholar
• Fujita K, Kada S, Kanai O, et al. Quantitative SARS-CoV-2 antibody screening of healthcare workers in the Southern part of Kyoto city during the COVID-19 pre-pandemic period. Front Public Health. 2020;8:595348.
   PubMed Web of Science ®Google Scholar
• Mahase E. Covid-19: antibody prevalence in England fell from 6.0% to 4.4% over three months, study finds. BMJ. 2020;371:m4163.
   PubMedGoogle Scholar
• Vogl T, Leviatan S, Segal E. SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population. Cell Rep Med. 2021;2(2):100191.
   PubMedGoogle Scholar
• Bradley T, Grundberg E, Selvarangan R. Antibody responses boosted in seropositive healthcare workers after single dose of SARS-CoV-2 mRNA vaccine. medRxiv. 2021.
   Google Scholar
• CDC. Interim guidelines for COVID-19 antibody testing; 2021 [cited 2021 Nov]. Available from: www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html
   Google Scholar
• Islam MN, Dipi RM, Mostafa SN, et al. Progression of disease in COVID-19 patients evaluated by chest CT imaging and correlated with clinical parameters. Mymensingh Med J. 2021;30(1):182–188.
   PubMedGoogle Scholar
• Waller JV, Kaur P, Tucker A, et al. Diagnostic tools for coronavirus disease (COVID-19): comparing CT and RT-PCR viral nucleic acid testing. AJR Am J Roentgenol. 2020;215(4):834–838.
   PubMed Web of Science ®Google Scholar
• Tofighi S, Najafi S, Johnston SK, et al. Low-dose CT in COVID-19 outbreak: radiation safety, image wisely, and image gently pledge. Emerg Radiol. 2020;27(6):601–605.
   PubMed Web of Science ®Google Scholar
• CDC. COVID-19 pooling procedures; 2021 [cited 2021 Nov 30]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/pooling-procedures.html
   Google Scholar
• Deka S, Kalita D, Mangla A, et al. Analysis of multi-sample pools in the detection of SARS-CoV-2 RNA for mass screening: an Indian perspective. Indian J Med Microbiol. 2020;38(3&4):451–456.
   PubMed Web of Science ®Google Scholar
• Vukičević D, Polašek O. Optimizing the diagnostic capacity for COVID-19 PCR testing for low resource and high demand settings: the development of information-dependent pooling protocol. J Glob Health. 2020;10(2):020515.
   PubMed Web of Science ®Google Scholar
• Mutesa L, Ndishimye P, Butera Y, et al. A pooled testing strategy for identifying SARS-CoV-2 at low prevalence. Nature. 2021;589(7841):276–280.
   PubMed Web of Science ®Google Scholar
• FDA. Emergency use authorisation (EUA) summary Viracor SARS-CoV-2 assay; 2021 [cited 2021 Nov 30]. Available from: https://www.fda.gov/media/143069/download
   Google Scholar
• PerkinElmer. Instructions for PerkinElmer® new coronavirus nucleic acid detection kit; v 9.0; 2020 [cited 2021 Nov 30]. Available from: https://www.fda.gov/media/136410/download
   Google Scholar
• Public Health England. Standard operating procedure: pooling of asymptomatic SARS-CoV-2 COVID-19 sample for (PCR/or other) testing; version 1; 2020 [cited 2021 Nov 30]. Available from: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/09/C0777-sample-pooling-sop-v1.pdf
   Google Scholar
• Petrovan V, Vrajmasu V, Bucur AC, et al. Evaluation of commercial qPCR kits for detection of SARS-CoV-2 in pooled samples. Diagnostics. 2020;10(7):472.
   Web of Science ®Google Scholar
• Torres I, Albert E, Navarro D. Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR. J Med Virol. 2020;92(11):2306–2307.
   PubMed Web of Science ®Google Scholar
• CDC. COVID-19 testing: what you need to know; 2020 [cited 2021 Nov 30]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html
   Google Scholar
• Mallett S, Allen AJ, Graziadio S, et al. At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data. BMC Med. 2020;18(1):346.
   PubMed Web of Science ®Google Scholar
• Sethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA. 2020;323(22):2249–2251.
   PubMed Web of Science ®Google Scholar
• Frnda J, Durica M. On pilot massive COVID-19 testing by antigen tests in Europe. Case study: Slovakia. Infect Dis Rep. 2021;13(1):45–57.
   PubMed Web of Science ®Google Scholar
• Singanayagam A, Hakki S, Dunning J, et al. Community transmission and viral load kinetics of the SARS-CoV-2 Delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2022;22:183–195.
   PubMed Web of Science ®Google Scholar
• Elliott P, Haw D, Wang H, et al. Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant. Science. 2021;374:eabl9551.
   PubMed Web of Science ®Google Scholar
• WHO. Living guidance for clinical management of COVID-19; 2021 [cited 2021 Dec 2]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2
   Google Scholar
• Waudby-West R, Parcell BJ, Palmer CNA, et al. The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort. Eur Respir J. 2021;58(1):2100360.
   PubMed Web of Science ®Google Scholar
• Shah VP, Farah WH, Hill JC, et al. Association between SARS-CoV-2 cycle threshold values and clinical outcomes in patients with COVID-19: a systematic review and meta-analysis. Open Forum Infect Dis. 2021;8(9):ofab453.
   PubMed Web of Science ®Google Scholar
• Rao SN, Manissero D, Steele VR, et al. A systematic review of the clinical utility of cycle threshold values in the context of COVID-19. Infect Dis Ther. 2020;9(3):573–586.
   PubMed Web of Science ®Google Scholar
• Mayers C, Baker K. Impact of false-positives and false-negatives in the UK’s COVID-19 RT-PCR testing programme; 2020 [cited 2021 Nov]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/895843/S0519_Impact_of_false_positives_and_negatives.pdf
   Google Scholar
• Healy B, Khan A, Metezai H, et al. The impact of false positive COVID-19 results in an area of low prevalence. Clin Med. 2021;21(1):e54–e56.
   PubMed Web of Science ®Google Scholar
• Tom MR, Mina MJ. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin Infect Dis. 2020;71(16):2252–2254.
   PubMed Web of Science ®Google Scholar
• Engelmann I, Alidjinou EK, Ogiez J, et al. Preanalytical issues and cycle threshold values in SARS-CoV-2 real-time RT-PCR testing: should test results include these? ACS Omega. 2021;6(10):6528–6536.
   PubMed Web of Science ®Google Scholar
• Rabaan AA, Tirupathi R, Sule AA, et al. Viral dynamics and real-time RT-PCR Ct values correlation with disease severity in COVID-19. Diagnostics. 2021;11(6):1091.
   Web of Science ®Google Scholar
• Boger B, Fachi MM, Vilhena RO, et al. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. Am J Infect Control. 2021;49(1):21–29.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gonzalez E, Lara-Mayorga IM, Rodriguez-Sanchez IP, et al. Colorimetric loop-mediated isothermal amplification (LAMP) for cost-effective and quantitative detection of SARS-CoV-2: the change in color in LAMP-based assays quantitatively correlates with viral copy number. Anal Methods. 2021;13(2):169–178.
   PubMed Web of Science ®Google Scholar
• Huang WE, Lim B, Hsu CC, et al. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2. Microb Biotechnol. 2020;13(4):950–961.
   PubMed Web of Science ®Google Scholar
• Nagura-Ikeda M, Imai K, Tabata S, et al. Clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR (RT-qPCR), direct RT-qPCR, reverse transcription-loop-mediated isothermal amplification, and a rapid antigen test to diagnose COVID-19. J Clin Microbiol. 2020;58(9):e01438-20.
   PubMed Web of Science ®Google Scholar
• Olalekan A, Iwalokun B, Akinloye OM, et al. COVID-19 rapid diagnostic test could contain transmission in low- and middle-income countries. Afr J Lab Med. 2020;9(1):1255.
   PubMed Web of Science ®Google Scholar
• Schultz MJ, Gebremariam TH, Park C, et al. Pragmatic recommendations for the use of diagnostic testing and prognostic models in hospitalized patients with severe COVID-19 in low- and middle-income countries. Am J Trop Med Hyg. 2021;104(3_Suppl.):34–47.
   PubMed Web of Science ®Google Scholar
• Peeling RW, Olliaro PL, Boeras DI, et al. Scaling up COVID-19 rapid antigen tests: promises and challenges. Lancet Infect Dis. 2021;21(9):e290–e295.
   PubMed Web of Science ®Google Scholar
• WHO. Technical guidance on laboratory operations for coronavirus disease (COVID-19) testing in the WHO African region. Version 1.0; 2021 [cited 2021 Nov 30]. Available from: https://www.afro.who.int/sites/default/files/Covid-19/Techinical%20documents/Technical%20guidance%20on%20laboratory%20operations%20for%20coronavirus%20disease%20COVID-19%20testing%20in%20the%20WHO%20African%20region.pdf
   Google Scholar
• Boum Y, Fai KN, Nikolay B, et al. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study. Lancet Infect Dis. 2021;21(8):1089–1096.
   PubMed Web of Science ®Google Scholar
• Gupta A, Khurana S, Das R, et al. Rapid chromatographic immunoassay-based evaluation of COVID-19: a cross-sectional, diagnostic test accuracy study & its implications for COVID-19 management in India. Indian J Med Res. 2021;153(1&2):126–131.
   PubMed Web of Science ®Google Scholar
• FDA. Coronavirus disease 2019. Testing basics 2019; 2019 [cited 2021 Feb]. Available from: https://www.fda.gov/consumers/consumer-updates/coronavirus-disease-2019-testing-basics
   Google Scholar
• European Centers for Disease Prevention and Control. Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK; 2020 [cited 2021 Feb]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/Options-use-of-rapid-antigen-tests-for-COVID-19.pdf
   Google Scholar
• CDC. Antigen testing guidelines; 2020 [cited 2021 Feb]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html
   Google Scholar
• Protzer UKI, Renz H, Busch D, et al. Position paper of the B-FAST network in the National Research Network of University Medicine on COVID-19 on the application and approval practice of rapid antigen tests for the detection of the new coronavirus, SARS-CoV-2; 2021 [cited 2021 Feb]. Available from: https://g-f-v.org/wp-content/uploads/2021/08/B-FAST_Positionspapier_SARS-CoV-2-Ag-Schnelltests-002.pdf
   Google Scholar
• Carpenter CR. Rapid antigen and molecular tests had varied sensitivity and ≥97% specificity for detecting SARS-CoV-2 infection. Ann Intern Med. 2020;173(12):JC69.
   PubMed Web of Science ®Google Scholar
• Mak GC, Cheng PK, Lau SS, et al. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J Clin Virol. 2020;129:104500.
   PubMed Web of Science ®Google Scholar
• Chan CP, Wong NS, Leung CC, et al. Positive impact of measures against COVID-19 on reducing influenza in the Northern hemisphere. J Travel Med. 2020;27(8):taaa087.
   PubMed Web of Science ®Google Scholar
• Chow A, Hein AA, Kyaw WM. Unintended consequence: influenza plunges with public health response to COVID-19 in Singapore. J Infect. 2020;81(2):e68–e69.
   PubMed Web of Science ®Google Scholar
• Kuo SC, Shih SM, Chien LH, et al. Collateral benefit of COVID-19 control measures on influenza activity, Taiwan. Emerg Infect Dis. 2020;26(8):1928–1930.
   PubMed Web of Science ®Google Scholar
• Noh JY, Seong H, Yoon JG, et al. Social distancing against COVID-19: implication for the control of influenza. J Korean Med Sci. 2020;35(19):e182.
   PubMed Web of Science ®Google Scholar
• Olsen SJ, Azziz-Baumgartner E, Budd AP, et al. Decreased influenza activity during the COVID-19 pandemic – United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1305–1309.
   PubMed Web of Science ®Google Scholar
• Stowe J, Tessier E, Zhao H, et al. Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design. Int J Epidemiol. 2021;50(4):1124–1133.
   PubMed Web of Science ®Google Scholar
• Dantas LF, Peres IT, Bastos LSL, et al. App-based symptom tracking to optimize SARS-CoV-2 testing strategy using machine learning. PLoS One. 2021;16(3):e0248920.
   PubMed Web of Science ®Google Scholar
• Mockel M, Corman VM, Stegemann MS, et al. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department. Biomarkers. 2021;26(3):213–220.
   PubMed Web of Science ®Google Scholar
• Wake RM, Morgan M, Choi J, et al. Reducing nosocomial transmission of COVID-19: implementation of a COVID-19 triage system. Clin Med. 2020;20(5):e141–e145.
   PubMed Web of Science ®Google Scholar
• Huang J, Zheng L, Li Z, et al. Kinetics of SARS-CoV-2 positivity of infected and recovered patients from a single center. Sci Rep. 2020;10(1):18629.
   PubMed Web of Science ®Google Scholar
• Kim SM, Hwang YJ, Kwak Y. Prolonged SARS-CoV-2 detection and reversed RT-PCR results in mild or asymptomatic patients. Infect Dis. 2021;53(1):31–37.
   PubMed Web of Science ®Google Scholar
• Landi F, Gremese E, Rota E, et al. Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: when does quarantine really end? J Infect. 2020;81(6):e1–e3.
   PubMed Web of Science ®Google Scholar
• FDA. COVID-19 test uses: FAQs on testing for SARS-CoV-2; 2021 [cited 2021 Dec 2]. Available from: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/covid-19-test-uses-faqs-testing-sars-cov-2
   Google Scholar
• Carpenter CR, Mudd PA, West CP, et al. Diagnosing COVID-19 in the emergency department: a scoping review of clinical examinations, laboratory tests, imaging accuracy, and biases. Acad Emerg Med. 2020;27(8):653–670.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Novel coronavirus (SARS-CoV-2): discharge criteria for confirmed COVID-19 cases – when is it safe to discharge COVID-19 cases from the hospital or end home isolation? 2020 [cited 2021 Feb]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-Discharge-criteria.pdf
   Google Scholar
• CDC. Discontinuation of transmission-based precautions and disposition of patients with SARS-CoV-2 infection in healthcare settings; 2021 [cited 2021 Mar]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-patients.html
   Google Scholar
• Robert Koch Institute. COVID-19: release criteria from isolation; 2021 [cited 2021 Mar]. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Entlassmanagement.html;jsessionid=5BED1087E0E0E4BCC211959326363099.internet061?nn=13490888
   Google Scholar
• Elsayed SM, Reddy MK, Murthy PM, et al. The possibility and cause of relapse after previously recovering from COVID-19: a systematic review. Cureus. 2020;12(9):e10264.
   PubMed Web of Science ®Google Scholar
• Nakajima Y, Ogai A, Furukawa K, et al. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient. J Infect Chemother. 2021;27(2):387–389.
   PubMed Web of Science ®Google Scholar
• Manzulli V, Scioscia G, Giganti G, et al. Real time PCR and culture-based virus isolation test in clinically recovered patients: is the subject still infectious for SARS-CoV2? J Clin Med. 2021;10(2):309.
   PubMed Web of Science ®Google Scholar
• Piralla A, Ricchi M, Cusi MG, et al. Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: is prolonged quarantine always justified? Int J Infect Dis. 2021;102:299–302.
   PubMed Web of Science ®Google Scholar
• Public Health England. Understanding cycle threshold (Ct) in SARS-CoV-2 RT-PCR: a guide for health protection teams; 2020 [cited 2021 Nov]. Available from: https://www.gov.uk/government/publications/cycle-threshold-ct-in-sars-cov-2-rt-pcr
   Google Scholar
• Buchta C, Görzer I, Chiba P, et al. Variability of cycle threshold values in an external quality assessment scheme for detection of the SARS-CoV-2 virus genome by RT-PCR. Clin Chem Lab Med. 2021;59(5):987–994.
   PubMed Web of Science ®Google Scholar
• Lohse S, Pfuhl T, Berko-Gottel B, et al. Pooling of samples for testing for SARS-CoV-2 in asymptomatic people. Lancet Infect Dis. 2020;20(11):1231–1232.
   PubMedGoogle Scholar
• Scohy A, Anantharajah A, Bodeus M, et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020;129:104455.
   PubMed Web of Science ®Google Scholar
• Department for Digital Culture Media & Sport. Policy paper events research program: phase I findings; 2021 [cited 2021 Nov]. Available from: https://www.gov.uk/government/publications/events-research-programme-phase-i-findings/events-research-programme-phase-i-findings
   Google Scholar
• Torjesen I. Covid-19: events pilot finds “no substantial outbreaks,” but experts point to gaps in evidence. BMJ. 2021;373:n1658.
   PubMedGoogle Scholar
• CDC. Required testing before air travel to the US; 2021 [cited 2021 Nov]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/travelers/testing-international-air-travelers.html
   Google Scholar
• Department for Transport. Travel to England from another country during coronavirus (COVID-19); 2021 [cited 2021 Nov]. Available from: https://www.gov.uk/guidance/travel-to-england-from-another-country-during-coronavirus-covid-19
   Google Scholar
• European Center for Disease Prevention and Control. Infection prevention and control and preparedness for COVID-19 in healthcare settings; 2021 [cited 2021 Feb]. Available from: https://www.ecdc.europa.eu/en/publications-data/infection-prevention-and-control-and-preparedness-covid-19-healthcare-settings
   Google Scholar
• Gholami M, Fawad I, Shadan S, et al. COVID-19 and healthcare workers: a systematic review and meta-analysis. Int J Infect Dis. 2021;104:335–346.
   PubMed Web of Science ®Google Scholar
• DiFiori JP, Green G, Meeuwisse W, et al. Return to sport for North American professional sport leagues in the context of COVID-19. Br J Sports Med. 2021;55(8):417–421.
   PubMed Web of Science ®Google Scholar
• Mooney M, Perera NKP, Broderick C, et al. A deep dive into testing and management of COVID-19 for Australian high performance and professional sport. J Sci Med Sport. 2020;23(7):664–669.
   PubMed Web of Science ®Google Scholar
• Pedersen L, Lindberg J, Lind RR, et al. Reopening elite sport during the COVID-19 pandemic: experiences from a controlled return to elite football in Denmark. Scand J Med Sci Sports. 2021;31(4):936–939.
   PubMed Web of Science ®Google Scholar
• Viner RM, Mytton OT, Bonell C, et al. Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: a systematic review and meta-analysis. JAMA Pediatr. 2021;175(2):143–156.
   PubMed Web of Science ®Google Scholar
• Otte Im Kampe E, Lehfeld A-S, Buda S, et al. Surveillance of COVID-19 school outbreaks, Germany, March to August 2020. Eurosurveill. 2020;25(38):2001645.
   Web of Science ®Google Scholar
• Rivasi G, Bulgaresi M, Mossello E, et al. Course and lethality of SARS-CoV-2 epidemic in nursing homes after vaccination in Florence, Italy. Vaccines. 2021;9(10):1174.
   PubMed Web of Science ®Google Scholar
• Domi M, Leitson M, Gifford D, et al. The BNT162b2 vaccine is associated with lower new COVID-19 cases in nursing home residents and staff. J Am Geriatr Soc. 2021;69(8):2079–2089.
   PubMed Web of Science ®Google Scholar
• Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615.
   PubMed Web of Science ®Google Scholar
• WHO. COVID-19 natural immunity: scientific brief; 2021 [cited 2021 Nov]. Available from: https://apps.who.int/iris/handle/10665/341241
   Google Scholar
• Manisty C, Otter AD, Treibel TA, et al. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. Lancet. 2021;397(10279):1057–1058.
   PubMed Web of Science ®Google Scholar
• Steensels D, Pierlet N, Penders J, et al. Comparison of SARS-CoV-2 antibody response following vaccination with BNT162b2 and mRNA-1273. JAMA. 2021;326(15):1533–1535.
   PubMed Web of Science ®Google Scholar
• The New York Times. Coronavirus vaccine tracker; 2021 [cited 2021 Mar]. Available from: https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html
   Google Scholar
• Muller L, Ostermann PN, Walker A, et al. Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting. Eur J Clin Microbiol Infect Dis. 2021;40(5):1063–1071.
   PubMed Web of Science ®Google Scholar
• Kohmer N, Westhaus S, Ruhl C, et al. Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays. J Clin Virol. 2020;129:104480.
   PubMed Web of Science ®Google Scholar
• WHO. Guidelines on clinical evaluation of vaccine: regulatory expectations; 2016 [cited 2021 Feb]. Available from: https://www.who.int/biologicals/expert_committee/Clinical_changes_IK_final.pdf
   Google Scholar
• Ozcurumez MK, Ambrosch A, Frey O, et al. SARS-CoV-2 antibody testing-questions to be asked. J Allergy Clin Immunol. 2020;146(1):35–43.
   PubMed Web of Science ®Google Scholar
• Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205–1211.
   PubMed Web of Science ®Google Scholar
• Kristiansen PA, Page M, Bernasconi V, et al. WHO international standard for anti-SARS-CoV-2 immunoglobulin. Lancet. 2021;397(10282):1347–1348.
   PubMed Web of Science ®Google Scholar
• Feng S, Phillips DJ, White T, et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 2021;27(11):2032–2040.
   PubMed Web of Science ®Google Scholar
• CDC. Variants and genomic surveillance for SARS-CoV-2; 2021 [cited 2021 Feb]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance.html
   Google Scholar
• Wu K, Werner AP, Moliva JI, et al. mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. bioRxiv. 2021.
   Google Scholar
• European Centre for Disease Prevention and Control. Methods for the detection and identification of SARS-CoV-2 variants; 2021 [cited 2021 Nov]. Available from: https://www.ecdc.europa.eu/en/publications-data/methods-detection-and-identification-sars-cov-2-variants
   Google Scholar
• FDA. Genetic variants of SARS-CoV-2 may lead to false negative results with molecular tests for detection of SARS-CoV-2 – letter to clinical laboratory staff and health care providers; 2021 [cited 2021 Feb]. Available from: https://www.fda.gov/medical-devices/letters-health-care-providers/genetic-variants-sars-cov-2-may-lead-false-negative-results-molecular-tests-detection-sars-cov-2
   Google Scholar
• Lee LYW, Rozmanowski S, Pang M, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission. Clin Infect Dis. 2021;74(3):407–415.
   Google Scholar
• Hayden RT, Caliendo AM. Persistent challenges of interassay variability in transplant viral load testing. J Clin Microbiol. 2020;58(10):e00782-20.
   PubMed Web of Science ®Google Scholar
• Krammer F. Correlates of protection from SARS-CoV-2 infection. Lancet. 2021;397(10283):1421–1423.
   PubMed Web of Science ®Google Scholar
• Javalkote VS, Kancharla N, Bhadra B, et al. CRISPR-based assays for rapid detection of SARS-CoV-2. Methods. 2020.
   Google Scholar
• Xiong E, Jiang L, Tian T, et al. Simultaneous dual-gene diagnosis of SARS-CoV-2 based on CRISPR/Cas9-mediated lateral flow assay. Angew Chem Int Ed Engl. 2021;60(10):5307–5315.
   PubMed Web of Science ®Google Scholar